Literature DB >> 29215611

Parietal Cell Protrusions and Dilated Oxyntic Glands from Use of Vonoprazan.

Shuichi Miyamoto1, Yoshihiro Matsuno2, Mototsugu Kato3, Takahiko Kudo1, Shouko Ono4, Yuichi Shimizu4, Naoya Sakamoto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29215611     DOI： 10.1038/ajg.2017.364

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

1.  Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.

Authors:  Izumi Tsuchiya; Yuri Kato; Emiko Tanida; Yoshifumi Masui; Shingo Kato; Atsushi Nakajima; Motoyoshi Izumi
Journal:  Dig Endosc       Date:  2017-04-05       Impact factor: 7.559

2.  Gastric mucosal cracked and cobblestone-like changes resulting from proton pump inhibitor use.

Authors:  Shuichi Miyamoto; Mototsugu Kato; Momoko Tsuda; Kana Matsuda; Tetsuhito Muranaka; Satoshi Abiko; Masayoshi Ono; Takeshi Mizushima; Saori Omori; Keiko Yamamoto; Katsuhiro Mabe; Shoko Ono; Takahiko Kudo; Yuichi Shimizu; Naoya Sakamoto
Journal:  Dig Endosc       Date:  2017-01-22       Impact factor: 7.559

Review 3.  Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.

Authors:  Y S Jung; E H Kim; C H Park
Journal:  Aliment Pharmacol Ther       Date:  2017-05-12       Impact factor: 8.171

4.  Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.

Authors:  Kirthi R Kumar; Ramiz Iqbal; Elizabeth Coss; Christina Park; Byron Cryer; Robert M Genta
Journal:  Hum Pathol       Date:  2013-09-24       Impact factor: 3.466

5.  Radiographic Localization Study of a Novel Potassium-Competitive Acid Blocker, Vonoprazan, in the Rat Gastric Mucosa.

Authors:  Jun Matsukawa; Akifumi Kogame; Yoshihiko Tagawa; Nobuhiro Inatomi
Journal:  Dig Dis Sci       Date:  2016-03-09       Impact factor: 3.199
  5 in total
  2 in total

Review 1.  Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker.

Authors:  Hideki Mori; Hidekazu Suzuki
Journal:  J Neurogastroenterol Motil       Date:  2019-01-31       Impact factor: 4.924

2.  Vonoprazan-associated Gastric Mucosal Redness: A Report of Four Cases.

Authors:  Kimitoshi Kubo; Noriko Kimura; Soichiro Matsuda; Momoko Tsuda; Katsuhiro Mabe; Mototsugu Kato
Journal:  Intern Med       Date:  2019-10-15       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.